References
- LiangXBiSYangWReprint of: epidemiological serosurvey of hepatitis B in China – declining HBV prevalence due to hepatitis B vaccinationVaccine201331suppl 9J21J2823948229
- LiangXBiSYangWEpidemiological serosurvey of hepatitis B in China – declining HBV prevalence due to hepatitis B vaccinationVaccine200927476550655719729084
- FanJGFarrellGCEpidemiology of non-alcoholic fatty liver disease in ChinaJ Hepatol200950120421019014878
- Fatty Liver and Alcoholic Liver Disease Study Group of Chinese Liver Disease AssociationDiagnostic criteria of nonalcoholic fatty liver diseaseZhonghua Gan Zang Bing Za Zhi200311271 Chinese12648394
- YajimaYOhtaKNaruiTAbeRSuzukiHOhtsukiMUltrasonographical diagnosis of fatty liver: significance of the liver-kidney contrastTohoku J Exp Med1983139143506220488
- ZengMDFanJGLuLGGuidelines for the diagnosis and treatment of nonalcoholic fatty liver diseasesJ Dig Dis20089210811218419645
- FarrellGCChitturiSLauGKSollanoJDGuidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summaryJ Gastroenterol Hepatol200722677577717565629
- ChitturiSFarrellGCHashimotoENon-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelinesJ Gastroenterol Hepatol200722677878717565630
- FanJGJiaJDLiYMGuidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology. 2010;18:163–166)J Dig Dis2011121384421276207
- Jian-gaoFGuidelines for management of nonalcoholic fatty liver disease: an updated and revised editionZhonghua Gan Zang Bing Za Zhi201018316316620698076
- AmarapurkarDNHashimotoELesmanaLAHow common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?J Gastroenterol Hepatol200722678879317565631
- FanJGSaibaraTChitturiSWhat are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?J Gastroenterol Hepatol200722679480017498218
- HaymanAVSofairANManosMMPrevalence and predictors of hepatic steatosis in adults with newly diagnosed chronic liver disease due to hepatitis CMedicine (Baltimore)200988530230619745689
- GordonAMcLeanCAPedersenJSBaileyMJRobertsSKHepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosisJ Hepatol2005431384415876468
- PersicoMIolasconASteatosis as a co-factor in chronic liver diseasesWorld J Gastroenterol201016101171117620222159
- JinXChenYPYangYDLiYMZhengLXuCQAssociation between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis BPLoS One201273e3419822479562
- CeylanBArslanFBatirelAImpact of fatty liver on hepatitis B virus replication and virologic response to tenofovir and entecavirTurk J Gastroenterol2016271424626674977
- Chinese Society of Hepatology, Chinese Medical AssociationChinese Society of Infectious Diseases, Chinese Medical AssociationHouJLLaiWThe guideline of prevention and treatment for chronic hepatitis B: a 2015 updateZhonghua Gan Zang Bing Za Zhi20152312888905 Chinese26739464
- IcerSCoskunAIkizceliTQuantitative grading using grey relational analysis on ultrasonographic images of a fatty liverJ Med Syst20123642521252821526330
- AtesFYalnizMAlanSImpact of liver steatosis on response to pegylated interferon therapy in patients with chronic hepatitis BWorld J Gastroenterol201117404517452222110283